NEW YORK (360Dx) – After several months of healthy growth, shares of many diagnostic firms contracted in September as the 360 Index was relatively flat month over month.

Overall, the stock prices for 14 companies in the index were down during the month while 13 firms' share prices fell. The index lagged the Dow Jones Industrial Average, which grew 2 percent month over month, but was slightly ahead of the Nasdaq Composite and the Nasdaq Biotech Index, each of which were down a fraction of 1 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.